143 related articles for article (PubMed ID: 25758415)
1. 3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity.
Mudududdla R; Guru SK; Wani A; Sharma S; Joshi P; Vishwakarma RA; Kumar A; Bhushan S; Bharate SB
Org Biomol Chem; 2015 Apr; 13(14):4296-309. PubMed ID: 25758415
[TBL] [Abstract][Full Text] [Related]
2. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
4. Anti-breast cancer activity of some novel quinoline derivatives.
Ghorab MM; Alsaid MS
Acta Pharm; 2015 Sep; 65(3):271-83. PubMed ID: 26431105
[TBL] [Abstract][Full Text] [Related]
5. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
Shi L; Wu TT; Wang Z; Xue JY; Xu YG
Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
Bharate JB; Singh S; Wani A; Sharma S; Joshi P; Khan IA; Kumar A; Vishwakarma RA; Bharate SB
Org Biomol Chem; 2015 May; 13(19):5424-31. PubMed ID: 25865846
[TBL] [Abstract][Full Text] [Related]
8. Novel quinolines carrying pyridine, thienopyridine, isoquinoline, thiazolidine, thiazole and thiophene moieties as potential anticancer agents.
Ghorab MM; Alsaid MS; Al-Dosari MS; Ragab FA; Al-Mishari AA; Almoqbil AN
Acta Pharm; 2016 Jun; 66(2):155-71. PubMed ID: 27279061
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor cell growth and angiogenesis by 7-aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors.
Ravez S; Barczyk A; Six P; Cagnon A; Garofalo A; Goossens L; Depreux P
Eur J Med Chem; 2014 May; 79():369-81. PubMed ID: 24747748
[TBL] [Abstract][Full Text] [Related]
10. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors.
AbdElhameid MK; Labib MB; Negmeldin AT; Al-Shorbagy M; Mohammed MR
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1472-1493. PubMed ID: 30191744
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding.
Chu C; Noël-Hudson MS; Bénard J; Ha-Duong T; Allaoui F; Farinotti R; Bonhomme-Faivre L
Eur J Pharm Sci; 2015 Aug; 76():18-26. PubMed ID: 25930120
[TBL] [Abstract][Full Text] [Related]
13. Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead.
Nallangi R; Samala G; Sridevi JP; Yogeeswari P; Sriram D
Eur J Med Chem; 2014 Apr; 76():110-7. PubMed ID: 24583350
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Cytotoxic Evaluation of Certain 7-Chloro-4-(piperazin-1-yl)quinoline Derivatives as VEGFR-II Inhibitors.
Aboul-Enein MN; El-Azzouny AM; Ragab FA; Hamissa MF
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28304102
[TBL] [Abstract][Full Text] [Related]
15. Identification of dual DNA-PK MDR1 inhibitors for the potentiation of cytotoxic drug activity.
Mould E; Berry P; Jamieson D; Hill C; Cano C; Tan N; Elliott S; Durkacz B; Newell D; Willmore E
Biochem Pharmacol; 2014 Mar; 88(1):58-65. PubMed ID: 24418411
[TBL] [Abstract][Full Text] [Related]
16. 6,7-Dimethoxy-2-{2-[4-(1H-1,2,3-triazol-1-yl)phenyl]ethyl}-1,2,3,4-tetrahydroisoquinolines as superior reversal agents for P-glycoprotein-mediated multidrug resistance.
Liu B; Qiu Q; Zhao T; Jiao L; Li Y; Huang W; Qian H
ChemMedChem; 2015 Feb; 10(2):336-44. PubMed ID: 25470220
[TBL] [Abstract][Full Text] [Related]
17. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
18. Benzo[b]thiophene-6-carboxamide 1,1-dioxides: inhibitors of human cancer cell growth at nanomolar concentrations.
Sagardoy AA; Gil MJ; Villar R; Viñas MJ; Arrazola A; Encío I; Martinez-Merino V
Bioorg Med Chem; 2010 Aug; 18(15):5701-7. PubMed ID: 20615714
[TBL] [Abstract][Full Text] [Related]
19. Colchicine derivatives with potent anticancer activity and reduced P-glycoprotein induction liability.
Singh B; Kumar A; Joshi P; Guru SK; Kumar S; Wani ZA; Mahajan G; Hussain A; Qazi AK; Kumar A; Bharate SS; Gupta BD; Sharma PR; Hamid A; Saxena AK; Mondhe DM; Bhushan S; Bharate SB; Vishwakarma RA
Org Biomol Chem; 2015 May; 13(20):5674-89. PubMed ID: 25895604
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines.
El-Readi MZ; Hamdan D; Farrag N; El-Shazly A; Wink M
Eur J Pharmacol; 2010 Jan; 626(2-3):139-45. PubMed ID: 19782062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
